Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,579
Total Claims
$641K
Drug Cost
356
Beneficiaries
$1,801
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+28%
Cost per patient vs peers
$1,801 vs $1,411 avg
-19%
Brand preference vs peers
8.7% vs 10.6% avg
Brand vs Generic
Brand: 825 claims · $430K
Generic: 8,701 claims · $209K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 56 | $61K |
| Sitagliptin Phos/Metformin Hcl | 43 | $34K |
| Apixaban | 52 | $31K |
| Empagliflozin | 43 | $30K |
| Dapagliflozin Propanediol | 32 | $28K |
| Sitagliptin Phosphate | 32 | $25K |
| Linaclotide | 44 | $24K |
| Linagliptin | 28 | $18K |
| Atorvastatin Calcium | 1,104 | $16K |
| Lactulose | 224 | $15K |
| Levothyroxine Sodium | 1,006 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 12 | $12K |
| Ipratropium/Albuterol Sulfate | 20 | $10K |
| Pantoprazole Sodium | 241 | $9,660 |
| Budesonide/Formoterol Fumarate | 16 | $9,292 |
Prescribing Profile
Patient Profile
62
Avg Age
45%
Female
1.37
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data